{"disease":{"id":"received-prior-first-line-chemotherapy-for-dlbcl-or-hgbl-failed-to-reach-cr-for-four-cycles-or-relapsed","name":"received prior first line chemotherapy for dlbcl or hgbl failed to reach cr for four cycles or relapsed"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05050630","title":"Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":73,"lead_sponsor_name":"Affiliated Hospital to Academy of Military Medical Sciences","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}